Silverstein Christine Berni

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 30% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Silverstein Christine Berni's trades of Abeona Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
5.86
Quantity 13,054
Value US$76,440
Transaction date
Proposed sale
Price
4.57
Quantity 27,500
Value US$125,675
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-06 2026-07-06
PrS Proposed sale
18,597
160.97
US$3,618,567 		18,597 160.97 US$3,618,567
2026-06-15 2026-06-15
S Sale
9,801 +42.3%
116.83
US$3,191,043 		9,801 +42.3% 116.83 US$3,191,043
2026-06-15 2026-06-15
PrS Proposed sale
60,627
248.02
US$36,821 		60,627 248.02 US$36,821
2026-02-09 2026-02-02
PrS Proposed sale
20,070
5.09
US$102,168 		20,070 5.09 US$102,168
2026-02-04 2026-02-02
S Sale
20,070 -12.7%
5.09
US$102,168 		20,070 -12.7% 5.09 US$102,168
2025-07-10 2025-07-09
S Sale
13,093 -9.8%
5.86
US$76,669 		13,093 -9.8% 5.86 US$76,669
2025-07-09 2025-07-09
PrS Proposed sale
13,054
5.86
US$76,440 		13,054 5.86 US$76,440
2024-06-20 2024-06-18
S Sale
25,821 -29.4%
4.51
US$116,453 		25,821 -29.4% 4.51 US$116,453
2024-06-17 2024-06-17
PrS Proposed sale
27,500
4.57
US$125,675 		27,500 4.57 US$125,675
2023-09-29 2023-09-27
S Sale
6,330 -6.7%
3.91
US$24,721 		6,330 -6.7% 3.91 US$24,721